Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic kidney disease (CKD) continues to be an ever-increasing health problem in the United States and elsewhere. Diabetes mellitus and hypertension remain the primary causes, and much of this is related to increased rates of
obesity
. Studies have demonstrated that early referral to a nephrologist can be life-saving and can also markedly improve quality of life. Besides recommending treatments for CKD, early referral can assist in medication management and in minimizing exposure to potential nephrotoxins. In patients who progress to end-stage renal disease, having an established patient-
PCP
-nephrologist relationship can ease the transition to renal replacement therapy or transplantation.
...
PMID:The primary care physician/nephrologist partnership in treating chronic kidney disease. 2543 37
Background:
Excessive weight gain in the first 2 years of childhood is a risk factor for future
obesity
. However, the current absence of clear, standardized identification and treatment guidelines may hinder primary care providers' (PCPs) ability to manage early excessive weight gain in children <2. The objective of this study was to explore PCPs' perspectives on evaluating and communicating about early excessive weight gain and to identify
PCP
-opined barriers to the care of children exhibiting such trends.
Methods:
A trained interviewer conducted 20 semistructured interviews with PCPs on identifying and communicating with families about early excessive weight gain in children <2 years old. A thematic analysis approach was used to analyze the transcripts.
Results:
Interviews uncovered three major themes: (1) the approach to identifying excessive weight gain in children <2 showed high variability across participants despite relative consistency in weight assessment methodology, (2) while possessing communication strategies, providers recognized multiple barriers impeding the execution of weight-related conversations with caregivers, and (3) providers perceived the need for additional support to improve their ability to respond to excessive weight gain in children <2 years old.
Conclusions:
Variability exists in
PCP
-reported methods used and barriers faced when identifying, communicating, and responding to excessive weight gain in very early childhood. Introducing guidelines and resources to help standardize the assessment and communication of excessive weight gain in children <2 could augment PCPs' strategies for managing accelerated weight-gain trajectories to mitigate rates of childhood
obesity
.
...
PMID:Managing Excessive Weight Gain in Children <2 Years of Age: Interviews with Primary Care Providers. 3246 May 26
Ethnopharmacological relevanceQuercetin is the active component of the higher content in
PCP
, which exerts various biological activities such as anti-
obesity
effect, anti-inflammatory and anti-oxidant activities in alcoholic liver disease (ALD).
...
PMID:Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway. 3318 1